Crescent Biopharma, Inc. Common Stock CBIO
$16.77
-2.39%
at last close
Financials (TTM)
- Revenue
- $119.38 million
- Net Income
- $-20,897,000
- Net Margin
- -17.50%
- Return on Equity
- -14.67%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 4.37
- Price / Sales
- 5.22
Over the trailing twelve months, Crescent Biopharma, Inc. Common Stock generated revenue of $119.38 million and net income of $-20,897,000, a net margin of -17.50%.
At the last closing price of $16.77, CBIO trades at 5.22 times sales, with a market capitalization of $622.95 million.
Key Stats
- Last Close
- $16.77
- Market Cap
- $622.95 million
- 52-Week Range
- $8.72 – $27.41
- Average Volume
- 275K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.